Table: Delta-Fly Pharma - 9-MTH parent results

Delta-Fly Pharma

14/02/2022 06:30

Feb 14 (Reuters)- 
             Delta-Fly Pharma, Inc. 
             PARENT-ONLY FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 9 months ended      9 months ended        Year to   
                Dec 31, 2021        Dec 31, 2020       Mar 31, 2022  
                   LATEST             YEAR-AGO            LATEST     
                   RESULTS             RESULTS           FORECAST    
  Sales            100 mln             100 mln           100 mln     
                 (+0.0 pct)                            (-66.7 pct)   
  Operating     loss 832 mln        loss 770 mln        loss 1.30    
  Recurring     loss 835 mln        loss 770 mln        loss 1.30    
  Net           loss 837 mln        loss 773 mln        loss 1.30    
  EPS          loss 154.65 yen     loss 171.63 yen   loss 239.87 yen 
  Ann Div                                NIL               NIL       
  -Q2 div            NIL                 NIL                         
  -Q4 div                                NIL               NIL       
  
  NOTE - Delta-Fly Pharma, Inc.. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4598.T